Last reviewed · How we verify
Olux-E Foam
At a glance
| Generic name | Olux-E Foam |
|---|---|
| Sponsor | Stiefel, a GSK Company |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis. (PHASE4)
- Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam (PHASE4)
- Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis (PHASE4)
- A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis (PHASE4)
- Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |